Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Viekirax and Exviera for Neuropsychiatric Manifestations in HCV
NCT03003338Phase 4Terminated
- Sponsor
- Hannover Medical School
- Start
- Oct 2017
- Primary completion
- Oct 2018
- Modality
- Allosteric Modulators, Orthosteric Ligands
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial of paritaprevir and dasabuvir in hepatitis C virus infection, sponsored by Hannover Medical School. Started Oct 2017; status: terminated.
02
Drugs
paritaprevirdasabuvir
03
Conditions
hepatitis C virus infection
Beyond the preview
Go deeper on NCT03003338.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03003338.